Crossword Cybersecurity Consulting Division Helps Digital Healthcare
Start-up Vital Signs Solutions Achieve Cyber Essentials Plus
16 March 2021 - London, UK - Crossword Cybersecurity Plc (AIM:CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focused on cyber security and risk management, is today announcing that its consulting division has helped Vital Signs Solutions, an early-stage, digital healthcare company, achieve the stringent standards of the UK Government's Cyber Essentials Plus certification, giving confidence to its patients, partners and regulators over its data security processes and protection of sensitive patient data.
Vital Signs Solutions' PocDoc® digital platform, was borne out of a vision of allowing anyone with a smartphone or tablet to test themselves for a range of major diseases and conditions. The end-to-end platform facilitates testing for health conditions via a fingerprick, and provides users with a full health assessment in minutes, offering solutions to address any health-related issues that arise. Most recently the PocDoc platform has been providing an end-to-end Covid-19 rapid testing solution for workplaces across the UK, allowing employers to enable a workforce to return to work in a Covid-safe way.
As a rapidly growing digital healthcare company with technology that has been highlighted by the NHS Digital Accelerator, operated by DigitalHealth.London as "HealthTech set to transform the NHS", a strong cyber security stance and the protection of patient data has always been of critical importance to Vital Signs Solutions. Working with the Crossword Consulting Team, a full review of every aspect of security processes and technology was undertaken to ensure the protection of data from the point of entry for its whole life, as well as ensure the resilience of the platform against cyber attacks.
Steve Roest, CEO & Co-founder of Vital Signs Solutions, said: "As a digital healthcare business, being responsible for patient data is fundamental to everything we do. The PocDoc platform is growing rapidly and Cyber Essentials Plus, with its need for a hands-on technical verification, rather than simple self-certification, ensures a strong security posture and foundation for growth that focuses on the trust placed in us by patients with their data."
Working closely with the board and technical teams at Vital Signs Solutions, Crossword was able to make a full assessment of internal networks and processes, before recommending and implementing where needed in the five key areas covered by Cyber Essentials Plus: Firewalls and Internet Gateways, Security Configuration, Access Control, Malware Protection and Patch Management. These improvements were then independently tested before certification was awarded. The success of project has been instrumental in helping Vital Signs Solutions scale as part of the NHS Digital Accelerator, which supports the uptake and spread of proven, impactful innovations across England's NHS.
Steve Roest, continued: "Our business is very fast moving and is developing rapidly. The work of the Crossword team has allowed us to implement stringent security measures and achieve certification in a way that doesn't introduce friction into the business and our processes, that slow us down or make us less agile. The work we have undertaken will be critical to our success in scaling out our PocDoc platform across multiple diseases in the UK and beyond."
Chris Wilkinson, Associate Director, Consulting at Crossword Cybersecurity PLC, added: "Digital health is an exciting high growth area, where extremely sensitive data is in the care of companies that are growing extremely fast. Cyber security is critically important and done well is not a drain on a company's financial and other resources. Our advice is to get started early with schemes such as Cyber Essentials Plus and other accreditations. Not only do they protect your business and the data under your stewardship, but they also open opportunities."
Contacts
Crossword Cybersecurity plc - Tel: +44 (0) 20 3953 8460
Email: info@crosswordcybersecurity.com
Tom Ilube, Chief Executive Officer
Mary Dowd, Chief Financial Officer
Grant Thornton (Nominated Adviser) - Tel: +44 (0) 20 7383 5100
Colin Aaronson / Jamie Barklem / Lukas Girzadas
Hybridan LLP (Broker) - Tel: +44 (0)203 764 2341
Claire Louise Noyce
For media enquiries contact:
Duncan Gurney, GingerPR
duncan@gingerpr.co.uk - Tel: +44 (0)1932 485 300
About Crossword Cybersecurity plc
Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security and risk management related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's leading product, is a SaaS platform that enables medium to large companies to assess and manage all risks from their suppliers. Nixer CyberML, Crossword's most recently launched product, is a new tool for businesses that want to solve advanced security and cybercrime problems, such as detecting and dealing with compromised accounts, fraud, and in-application denial of service attacks. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs.
About Vital Signs Solutions
Vital Signs Solutions is an early-stage, venture backed digital healthcare company focused on solving major global problems. The founding team has 30+ years of experience in medical device diagnostics, organic chemistry, immunology, virology and VC-backed, fast growth-high-value companies with global scale. The scientific R+D team has deep expertise in organic chemistry, microfluidics, blood-based biomarker analysis and image analysis to the highest level. They have an extensive network of some of the best investors and advisors across the medtech, digital health and consumer technology sectors.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
